AstraZeneca sees surge in Covid vaccine sales as jabs are rolled out globally

Drugs giant AstraZeneca has revealed sales of its Covid-19 vaccine soared to 1.2 billion US dollars (£860 million) in the first half as the global jab programme rolled out at pace.